Organizing Committee
OCM Member
Professor, Cardiology
Icahn School of Medicine at Mount Sinai , USA
Biography :

Franz H. Messerli, MD is an expert in hypertensive cardiovascular disease and preventive cardiology. He presently is Guest Professor in the Department of Cardiology and Clinical Research, University Hospital Bern, Switzerland, Professor of Medicine at Mount Sinai Health Medical Center, Icahn School of Medicine and Visiting Professor Jagiellonian University in Krakow, Poland. After earning his medical degree from the University of Bern Medical School in Switzerland, Dr. Messerli completed his post-graduate training in internal medicine and cardiology at the University of Bern. This was followed by a research fellowship at the Clinical Research Institute in Montreal, Canada. Before moving to New York, Dr. Messerli was for many years director of clinical research at the Ochsner Medical Institutions and Clinical Professor of Medicine at Tulane University School of Medicine in New Orleans. He served on the Cardio-Renal Advisory Committee of the Food and Drug Administration (FDA) and is a member of the editorial boards of Journal of the American College of Cardiology, European Heart Journal, Circulation, Hypertension, American Journal of Cardiology, Journal of Hypertension, etc. On his CV there are more than 1000 publications and he has been the first author on several papers in the New England Journal of Medicine, Lancet, Jama, and others. As a principal investigator, he participated in numerous clinical trials. For his scientific achievements, Dr. Messerli has received several awards among them an Honoris Causa Doctorate from the Jagiellonian University in Krakow, Poland and the Alberto Zanchetti Life Achievement Award of the European Society of Hypertension.

Research Interest :

Internal medicine and cardiology

OCM Member
Vice director in Onassis Cardiac-Surgery Center, Athens, Greece, cardiac patients’ clinical evaluation -treatment and routine- research cardiac MRI scans
Onassis Cardiac-Surgery Center , Greece
Biography :

Current Position: Cardiologist, Vice-director in Onassis Cardiac-Surgery Center, Athens, Greece. In charge of cardiac patients’ clinical evaluation -treatment and routine- research cardiac MRI scans. Visiting professor of Cardiovascular Magnetic Resonance, National and Kapodistrian University of Athens, Greece. ? Responsible for research cardiovascular MRI scans in Onassis Cardiac Surgery Center (a leading tertiary center in Athens), which is the only Greek center with active CMR research and publications. ? Routine scans include Cases with congenital heart disease (referred by cardiac surgeons). ARVD (referred by the cardiologists). Thalassemic patients (referred by hematologists for iron overload estimation). Duchenne and Becker myopathy cases (referred by neurologists for pre-symptomatic cardiac involvement evaluation). Patients with coronary aneurysm or ectasia and with Kawasaki syndrome (for coronary MRA). Vasculitis in rheumatic disease. Cardiac evaluation in different types of Rheumatic diseases (special interest in scleroderma). Myocarditis (infective, autoimmune, transplant rejection). ? Currently, our center has been included in the International Registry of Myocarditis, together with other International centers (Johns Hopkins, Mayo Clinic, Berlin, etc). ? Scientific advisor in Cardiovascular Magnetic Resonance of Paediatric Clinic of Kapodistrian University of Athens, Athens, Greece ? 1st President of the Greek CMR WG (1999-2002) ? Secretary to the Nucleus of the European Society of Cardiology CMR WG (2002) ? ESC CMR WG Nucleus Member (elected, 2004-2008) ? SCMR sessions organizing committee (2009-2010) ? Nominated by SCMR as non-USA CARDIOLOGIST (2010) ? Elected President of Women in CMR (Women working group of the International Society of Cardiovascular Magnetic Resonance) 2017

Research Interest :

MRI Unit

OCM Member
Professor, Head of Cardiology Department
Geneva University School of Medicine , Switzerland
Biography :

Prof. François Mach (h index >50), born in 1961, is an expert in the field of cardiology, in particular with regard to the development and progression of atherosclerosis diseases. After obtaining his MD at the University of Geneva, Switzerland, he studied internal medicine and cardiology at Geneva University Hospital. He then went on to complete a post-doctoral fellowship in the laboratory of Prof. Peter Libby, Brigham and Women’s Hospital, Boston (1995-1999). Following his return to Switzerland in 2000, he became full Professor of cardiology, and in 2006 he was appointed Head of the cardiology department at Geneva University Hospital. Between 2012-14, he was the President of the Swiss Society of Cardiology. François Mach is the author of more than 350 High Impact Factor publications, has obtained several European research grants (“European Vascular Genomics Network” [EVGN] FP6, “Inflammation and Vascular Wall Remodelling in Atherosclerosis” [AtheroRemo] FP7), and is currently involved in the Athero-B-Cell FP7 (Targeting and exploiting B cell function for treatment in cardiovascular disease, all funded by the European Community. As director of the cardiology basic science laboratory at the Faculty of the Medicine University of Geneva, Prof. François Mach and his research group have developed animal models of atherosclerosis, acute myocardial infarction, chronic myocardial ischemia, and ischemic stroke. During the last 10 years, the group of Prof. François Mach has substantially contributed to a better clarification of the inflammatory mechanisms underlying atherosclerosis and its acute dramatic complications, such as myocardial infarction and ischemic stroke, both in human cohorts and animal studies. For several years now, Prof. François Mach has also been strongly implicated in clinical research in the field of lipidology, by contributing to the design and completion of several clinical research projects and multi-center studies focussed on lipid-lowering agents, such as statins and, more recently, anti-PCSK9. In addition, he is also responsible for several Swiss cohorts of atherothrombotic patients and is one of the 3 co-chairs of the ESC 2019 Lipid Guidelines that will be published on September 1, 2019.

Research Interest :

Athero-B-Cell FP7 (Targeting and exploiting B cell function for treatment in cardiovascular disease)

OCM Member
German Heart Centre , United Arab Emirates
Biography :

Professor Dr. Uwe Klima, one of the world’s leading cardiac specialists, joined the German Heart Centre in 2015 and took over the clinic as Managing and Medical Director in July 2017. He holds a medical degree from the University of Vienna, and a PhD from the Hannover Medical School, Germany. Professor Klima was a resident and fellow in some of the world’s most prestigious hospitals and clinics including the Massachusetts General Hospital, Harvard Medical School, the Max Kade Foundation, and the Hannover Medical School in Germany. As one of the foremost cardiac - thoracic and vascular surgeons, Professor Klima performs advanced surgical procedures at affiliated hospitals in Dubai and provides valuable second opinions for patients considering invasive surgery. Languages Spoken: English, German

Research Interest :

thoracic and vascular surgeons

OCM Member
Madurai Kamaraj University , India
Biography :

Awarded with UGC– RAMAN Fellowship for Post-Doctoral Fellowship for Indian scholars in USA, 2016-2017. Invited as a chair on at DBT sponsored International conference on “Converging Biotechnological innovations for Health, Food and Environmental Welfare (ICCBI- 2015)”, December 2-4, 2015, Karunya University, Coimbatore, TamilNadu, India Invited as a chair on 7th Indo Global Diabetes Summit and Medicare Expo by OMICS Group Conferences, November 23-25, 2015, Bangalore, India. Special Award – Best Oral Presentation Award for “miRNA 99 family plays an indispensable role in determining the fate of cardiac hypertrophy” in UGC Sponsored National Conference on Emerging Protein Technologies for Formulation Solutions, October 16, 2015, Tumkur University. Special Award – Best Poster Award for “Are piRNAs a key player in cardiac hypertrophy?” in 11th Annual Conference of International Society for Heart Research (Indian Section), February 8-9, 2014, National Institute of Pharmaceutical Education And Research, Punjab, India. Education Background Sr.Assistant Professor Madurai Kamaraj University, Madurai, India. 2015- till date Research Assistant Professor Madurai Kamaraj University, Madurai, India. 2010- 2015 Post-Doctoral Researcher University of Temple, Philadelphia, PA, USA 2009- 2010 Post-Doctoral Researcher University of Alabama at Birmingham, USA 2007- 2008 Ph.D-Biochemistry Madurai Kamaraj University, Madurai, India. 2002- 2008 M. Phil- Zoology Madurai Kamaraj University, Madurai, India. 1998- 2000 M.Sc. Zoology Madurai Kamaraj University, Madurai, India. 1995- 1997 B.Sc. Zoology Madurai Kamaraj University, Madurai, India. 1992- 1995

Research Interest :

A study on the role of small Non-Coding RNA in Diabetic Heart Disease.

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
heartcongress@alliedforums.org
Sponsorship/Exhibitor/Advertising
cardiology@alliedgather.com
General Enquiry(WhatsApp)
heartcongress@alliedforums.org
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2019-2020 Allied Academies, All Rights Reserved.